EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 182 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $264,096 | +4.8% | 9,309 | +77.3% | 0.00% | -50.0% |
| Q2 2020 | $252,000 | -33.0% | 5,251 | -16.0% | 0.00% | -33.3% |
| Q4 2019 | $376,000 | -78.4% | 6,250 | -79.7% | 0.00% | -75.0% |
| Q3 2019 | $1,739,000 | -19.8% | 30,733 | -21.0% | 0.01% | -14.3% |
| Q2 2019 | $2,167,000 | +10.7% | 38,918 | +0.4% | 0.01% | +7.7% |
| Q1 2019 | $1,957,000 | +30.6% | 38,768 | +4.2% | 0.01% | +30.0% |
| Q4 2018 | $1,499,000 | -46.3% | 37,193 | -7.7% | 0.01% | -37.5% |
| Q3 2018 | $2,794,000 | -7.7% | 40,293 | +0.8% | 0.02% | -5.9% |
| Q2 2018 | $3,026,000 | +23.7% | 39,993 | -13.9% | 0.02% | +13.3% |
| Q1 2018 | $2,446,000 | +30.7% | 46,425 | +32.5% | 0.02% | +36.4% |
| Q4 2017 | $1,871,000 | +40.7% | 35,025 | +57.1% | 0.01% | +37.5% |
| Q3 2017 | $1,330,000 | – | 22,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 400,000 | $5,732,000 | 1.52% |
| Park West Asset Management LLC | 426,900 | $6,117,000 | 0.80% |
| WALL STREET ASSOCIATES | 200,000 | $2,866,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 284,653 | $4,079,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 100,000 | $1,433,000 | 0.02% |
| NEXT Financial Group, Inc | 2,500 | $26,000 | 0.01% |
| PIPER SANDLER & CO. | 1,277 | $18,000 | 0.01% |
| Ground Swell Capital, LLC | 400 | $6,000 | 0.01% |
| PARADIGM ASSET MANAGEMENT CO LLC | 6,300 | $90,279,000 | 0.01% |
| Paloma Partners Management Co | 14,363 | $206,000 | 0.01% |